According to a statement from the Endocrine Society, older men considering taking testosterone for low libido, fatigue, irritability or muscle loss should be made aware of the heart-related risks of testosterone therapy, as reported Chicago Tribune Thursday.
"Testosterone isn't approved for age-related conditions and age-related decline in testosterone levels," remarked statement co-author Shalender Bhasin, adding that studies have found most US men receiving testosterone therapy do not have documented testosterone measurements.
The society cautioned against widespread use of testosterone drugs until large-scale studies can be completed.
"Until more information on the risks of testosterone becomes available, older men who have pre-existing heart disease should be particularly careful about testosterone," Bhasin noted.
He said that testosterone had a market valued between $18 and $20 million in 1988 and was worth about $2.2 billion in 2013.
If you or a loved one had a heart attack, stroke or blood clot while taking a testosterone therapy medication, like AndroGel, please call our experienced Testosterone Therapy attorneys at (888) 606-5297 for a free consultation about your potential testosterone lawsuit.